357 related articles for article (PubMed ID: 1933781)
1. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
[TBL] [Abstract][Full Text] [Related]
2. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Tedesco M; Grassi A; Casale V; Cavaliere F; Greiner JW
J Surg Oncol Suppl; 1991; 2():16-20. PubMed ID: 1892526
[TBL] [Abstract][Full Text] [Related]
4. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of the new tumor marker TAG-72.
Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
7. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
Filella X; Fuster J; Molina R; Grau JJ; García-Valdecasas JC; Grande L; Estapé J; Ballesta AM
Acta Oncol; 1994; 33(7):747-51. PubMed ID: 7993641
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
9. Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinoma.
González A; Vizoso F; Allende MT; Sánchez MT; Balibrea JL; Ruibal A
Int J Biol Markers; 1996; 11(3):165-71. PubMed ID: 8915712
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.
Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Mariani-Costantini R; Greiner JW; Casciani CU; Schlom J
J Clin Oncol; 1996 Jul; 14(7):2031-42. PubMed ID: 8683233
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
13. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
Fernandes LC; Kim SB; Saad SS; Matos D
World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.
Bhatavdekar JM; Patel DD; Giri DD; Karelia NH; Vora HH; Ghosh N; Shah NG; Trivedi SN; Balar DB
Br J Cancer; 1992 Nov; 66(5):977-80. PubMed ID: 1419646
[TBL] [Abstract][Full Text] [Related]
15. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
17. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas.
Guadagni F; Roselli M; Amato T; Abbolito MR; Cosimelli M; Mannella E; Greiner JW; Schlom J
J Nucl Med Allied Sci; 1990; 34(4 Suppl):293-6. PubMed ID: 2092139
[No Abstract] [Full Text] [Related]
20. [Preoperative serum levels of the carcinoembryonic antigen (CEA) and prognosis in colorectal cancer].
Allende T; García Muñiz JL; Vizoso F; Del Casar JM; Raigoso P; Llana B; Serra C; Zeidán N; García-Morán M; Roiz C
Rev Esp Med Nucl; 2001 Aug; 20(5):358-64. PubMed ID: 11470069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
